NEW YORK (GenomeWeb News) – Siemens Healthcare has agreed to a five-year supply, distribution, sales, and service contract with Japanese firm Sysmex, Siemens said today.

The global agreement will cover distribution of a variety of diagnostic tests and coagulation instruments to test and monitor patients using blood thinning medications, Siemens said. The agreement also includes access to automated platelet function testing.

The firms also intend to continue joint product development efforts related to coagulation technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.